Orange and Stripe returned for a $75.9m round that cut the mobile bank's valuation from more than $2.5bn to under $1.6bn.

Grand Decade and existing investor Boehringer Ingelheim Venture Fund helped supply $38.2m for the mRNA immunotherapy developer and Vrije Universiteit Brussel spinout.

Continental Grain invested in a series D round that boosted the RNA technology provider's overall funding to $214m as it allocates more resources to vaccine work.

Returning investors Axel Springer and Purplebricks combined to invest $45.2m in the online real estate brokerage that will fund hiring and product development.

Next47 and M12 took part in Wandelbots' latest round, which came as it publicly launched its robotics training software tool.

The Eli Lilly and Genmab-backed RNA drug developer is now valued at nearly $1.5bn following a decision to refocus on a coronavirus vaccine.

The Microsoft and Disney-backed educational game portal pulled in $28m as investors also bought $62m of secondary shares.

OGCI Climate Investments led a $19.3m round for the digital freight platform operator that included existing backer Total Carbon Neutrality Ventures.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The retail collaboration platform developer has now raised more than $52m in total, existing backer SEB Alliance returning for a $23.9m round.